Skip to content
Search

Latest Stories

UHDB pharmacy team shortlisted for national award for preventing hundreds of hospital readmissions

UHDB pharmacy team shortlisted for national award for preventing hundreds of hospital readmissions

Thanks to the team's enhanced communications with community pharmacy teams, up to 760 hospital readmissions were prevented at UHDB since January 2023

Pharmacists at the University Hospitals of Derby and Burton (UHDB) are receiving national recognition for their outstanding efforts in improving patient safety beyond the hospital setting and reducing hospital readmissions.

The UHDB’s Medicines Optimisation team has been shortlisted for the prestigious Improving Medicines Safety Award at the upcoming HSJ Patient Safety Awards, which honours hard-working teams and individuals across the UK who are continually striving to deliver improved patient care.


In collaboration with digital services at the Trust and regional pharmacies, the team has developed an interface to improve communication with community pharmacies.

This system ensures that patients discharged from the hospital continue to receive the right medications they need, with safety reviews, after they leave the hospital's care.

This interface works alongside a national programme, called the Discharge Medicines Service (DMS), designed to enhance communication between hospitals and community pharmacies.

By ensuring that any changes to a patient's medication are accurately updated across the healthcare system, this system reduces the risk of patients encountering avoidable harm due to incorrect medications, allowing them to continue to recover well after discharge.

It is estimated that up to 760 hospital readmissions were prevented at UHDB since January 2023 following this initiative, which ensures patients have access to the correct medicines in the community.

Paul Thornley, Medicines Optimisation Project Lead at UHDB, expressed his pride at the team's hard work over many years to improving their service and enhancing patient safety:

"I'm incredibly proud of everyone's commitment and the impact this has had across our communities. The whole team got a real buzz when it was announced that we'd been shortlisted, and it's amazing to see everyone's work being highlighted on a national stage.

"We have always been keen to improve our service and communications between hospital and community pharmacy teams, so we are proud to have been shortlisted for our part in keeping our patients safe even after they leave our care."

Thanks to this interface, clinical pharmacy colleagues can now refer adult inpatients to their chosen community pharmacy upon discharge, ensuring that their medication is reviewed and updated across all their records.

Additionally, information about medication changes are effectively and clearly communicated with pharmacies in the community to avoid any potential risks.

This automated process helps patients continue receiving the correct medication, promoting recovery and reducing the risk of their condition worsening, which could otherwise lead to further hospital stays.

Paul explained: "We know that, nationally, around 80 per cent of patients are prescribed a new medication during a hospital admission, so improving the communication between pharmacies across the region is absolutely vital to ensure we're giving our patients the right care and the best chances of making a quicker recovery."

The team is now focussing on patients prescribed strong medications, such as opioids, during their hospital stay, to ensure they don’t continue taking them longer than needed after discharge, reducing the risk of developing a dependency or other associated complications.

Paul noted that while implementing this across two Electronic Prescribing and Medication Administration (ePMA) systems has been a huge challenge, the benefits are becoming clear.

UHDB is now among the top 25 per cent of trusts in the country using the service in this manner, with around 10 per cent of all adult inpatients being referred through this process.

The team aims to increase the number of patients who have their medication managed in this way.

"We are continuing to work closely with our community pharmacy colleagues, who have been incredibly helpful on this journey, and are aiming to increase our referral rates significantly to help further enhance patient safety, reduce preventable hospital admissions, and save valuable NHS resources,” Paul said.

The HSJ Patient Safety Awards ceremony, scheduled for 16 September, will also see two more UHDB teams in contention for the Urgent and Emergency Care Safety Initiative of the Year Award.

The Medical Same Day Urgent Care team has been shortlisted for their work in preventing hospital admissions for patients visiting the emergency department at Royal Derby Hospital.

Additionally, a pharmacy team based in the emergency department is shortlisted for reviewing medications for frailty patients, helping to prevent readmissions.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less